The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis
- 28 February 2006
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 184 (2), 342-347
- https://doi.org/10.1016/j.atherosclerosis.2005.05.004
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery diseaseAtherosclerosis, 2005
- Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levelsCytometry Part B: Clinical Cytometry, 2004
- Cross-linking of FcγR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163Journal of Leukocyte Biology, 2004
- Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular DiseaseCirculation Research, 2003
- Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemiaBlood, 2003
- Macrophage subpopulations in rheumatoid synovium: Reduced CD163 expression in CD4+ T lymphocyte–rich microenvironmentsArthritis & Rheumatism, 2002
- Soluble CD163: a marker molecule for monocyte/macrophage activity in diseaseScandinavian Journal of Clinical and Laboratory Investigation, 2002
- Soluble CD163 Inhibits Phorbol Ester-Induced Lymphocyte ProliferationBiochemical and Biophysical Research Communications, 2001
- Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosisAtherosclerosis, 1996
- The lungs as receptor sites for cardiovascular regulation.Circulation, 1981